Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin

Molecular Neurobiology

Volumn 19, Issue 1, 1999, Pages 79-96

  Nagatsu, T ^a   Ichinose, H ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

GCH; Pteridine; Tetrahydrobiopterin; TH

Indexed keywords

DOPAMINE; DYSPROPTERIN; GUANOSINE TRIPHOSPHATE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; NITRIC OXIDE SYNTHASE; PHENYLALANINE 4 MONOOXYGENASE; PTERIDINE; PTERIN; SEPIAPTERIN REDUCTASE; TETRAHYDROBIOPTERIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

AMINO ACID SEQUENCE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DYSTONIA; ENZYME DEFICIENCY; ENZYME REGULATION; GENE MUTATION; HUMAN; INHERITANCE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

EID: 0033042546     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02741379     Document Type: Article

References (88)

1. Nixon, J. C. (1985) Naturally occurring pterins, in Folates and Pterins, vol. 2 (Blakley, R. L. and Benkovic, S. J., eds.), John Wiley & Sons, New York, pp. 1-42.
2. Kaufman, S. (1963) The structure of the phenylalanine hydroxylase cofactor. Proc. Natl. Acad. Sci. USA 50, 1085-1093.
3. Matsuura, S., Sugimoto, T., Murata, S., Sugawara, Y., and Iwasaki, H. (1985) Stereochemistry of biopterin cofactor and facile methods for the determination of the stereochemistry of a biologically active 5,6,7,8-tetrahydrobiopterin. J. Biochem. 98, 1341-1348.
4. Kaufman, S. (1959) Studies on the mechanism of the enzymatic conversion of phenylalanine to tyrosine. J. Biol. Chem. 234, 2677-2688.
5. Nagatsu, T., Levitt M., and Udenfriend, S. (1964) Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem. 139, 2910-2917.
6. Lovenberg, W., Jequir, E., and Sjoerdsma, A. (1967) Tryptophan hydroxylase: Measurement in pineal gland, brain stem, and carcinoid tumor. Science 155, 217-219.
7. Tiets, A., Lindberg, M., and Kennedy, E. (1964) A new pteridine-requiring enzyme system for the oxidation of glyceryl ethers. J. Biol. Chem. 239, 4081-4090.
8. Kaufman, S., Pollock, R. J., Summer, G. K., Das, A. K., and Hajira, A. K. (1990) Dependence of an alkyl glycol-ether monooxygenase activity upon tetrahydropterins. Biochim. Biophys. Acta 1040, 19-27.
9. Tayeh, M. A., and Marletta, M. A. (1989) Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J. Biol. Chem. 264, 19654-19658.
10. Kwon, N. S., Nathan, C. F., and Stuehr, D. J. (1989) Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J. Biol. Chem. 264, 20,496-20,501.
11. Nagatsu, T. (1991) Genes for human catecholamine synthesizing enzymes. Neurosci. Res. 12, 315-345.
12. Nichol, C. A., Smith, G. K., and Duch, D. S. (1985) Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu. Rev. Biochem. 54, 729-762.
13. Kapatos, G. (1990) Tetrahydrobiopterin synthesis rate and turnover time in neuronal cultures from embryonic rat mesencephalon and hypothalamus. J. Neurochem. 55, 129-136.
14. Kapatos, G., Hirayama, K., and Hasegawa, H. (1992) Tetrahydrobiopterin turnover in cultured rat sympathetic neurons: Developmental profile, pharmacological sensitivity, and relationship to norepinephrine synthesis. J. Neurochem. 59, 2048-2055.
15. Levine, R. A., Miller, L. P., and Lovenberg, W. (1981) Tetrahydrobiopterin in the striatum: Localization in dopamine nerve terminals and role in catecholamine synthesis. Science 214, 919-921.
16. Oka, K., Ashiba, G., Sugimoto, T., Matsuura, S., and Nagatsu, T. (1982) Kinetic properties of tyrosine hydroxylase purified from bovine adrenal medulla and bovine candate nucleus. Biochim. Biophys. Acta 706, 188-196.
17. Hasegawa, H., and Ichiyama, A. (1987) Tryptophan 5-monooxygenase from mouse mastocytoma clone P815. Methods Enzymol. 142, 88-92.
18. Citron, B. A., Davis, M. D., and Kaufman, S. (1992) Purification and biochemical characterization of recombinant rat liver phenylalanine hydroxylase produced in Escherichia coli. Protein Expr. Purif. 3, 93-100.
19. Yui, Y., Hattori, R., Kosuga, K., Eizawa, H., Hiki, K., and Kawai, C. (1991) Purification of nitric oxide synthase from rat macrophages. J. Biol. Chem. 266, 12,544-12,547.
20. Zigmond, R. E., Schwarzchild, M. A., and Rittenhouse, A. R. (1989) Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu. Rev. Neurosci. 12, 415-461.
21. Spector, S., Gordon, R., Sjoerdsma, A., and Udenfriend, S. (1967) End-product inhibition of tyrosine hydroxylase as a possible mechanism of a regulation of norepinephrine biosynthesis. Mol. Pharmacol. 3, 549-555.
22. Kettler, R., Bartholini, G., and Pletscher, A. (1974) In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin. Nature 249, 476-478.
23. Hirata, Y., Togari, A., and Nagatsu, T. (1983) Studies on tyrosine hydroxylase system in rat brain slices using high-performace liquid chromatography with electrochemical detection. J. Neurochem. 40, 1585-1589.
24. Kaneda, N., Sasaoka, T., Kobayashi, K., Kiuchi, K., Nagatsu, T., Kurosawa, Y., Fujita, K., Yokoyama, M., Nomura, T., Katsuki, M., and Nagatsu, T. (1991) Tissue-specific and high-level expression of the human tyrosine hydroxylase gene in transgenic mice. Neuron 6, 583-594.
25. Nagatsu, T., Nakahara, D., Kobayashi, K., Morita, S., Sawada, H., Mizuguchi, T., and Kiuchi, K. (1994) Peripherally administered (6R)-tetrahydrobiopterin increases in vivo tyrosine hydroxylase activity in the striatum measured by microdialysis both in normal mice and in transgenic mice carrying human tyrosin hydroxylase. Neurosci. Lett. 182, 44-46.
26. Sawada, M., Sugimoto, T., Matsuura, S., and Nagatsu, T. (1986) (6R)-Tetrahydrobiopterin increases the activity of tryptophan hydroxylase in rat raphe slices. J. Neurochem. 47, 1544-1547.
27. Matsuura, S., Murata, S., Sugimoto, T., Sawada, M., and Nagatsu, T. (1986) Preparation and cofactor activity of (6S)-tetrahydrobiopterin. Chem. Expr. 1, 403-406.
28. Niwa, S., Watanabe, Y., and Hayaishi, O. (1985) 6R-L-Erythro-5,6,7,8-tetrahydrobiopterin as a regulator of dopamine and serotonin biosynthesis in the rat striatum. Arch. Biochem. Biophys. 239, 234-241.
29. Suzuki, S., Watanabe, Y., Tsubokura, S., Kagamiyama, H., and Hayaishi, O. (1988) Decrease in tetrahydrobiopterin content and neurotransmitter amine biosynthesis in rat brain by an inhibitor of guanosine triphosphate cyclohydrolase. Brain Res. 446, 1-10.
30. Ohta, A., Takagi, H., Matsui, T., Hamai, Y., Iida, S., and Esumi, H. (1993) Localization of nitricoxide synthase-immunoreactive neurons in the solitary nucleus and ventrolateral medulla oblongata of the rat: Their relation to catecholaminergic neurons. Neurosci. Lett. 158, 33-35.
31. Mayer, B., and Werner, E. R. (1995) in search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 453-463.
32. Schoedon, G., Schneemann, M., Hofer, S., Guerrero, L., Blau, N., and Schaffner, A. (1993) Regulation of the arginine-dependent and tetrahydrobiopterin-dependent biosynthesis of nitric oxide in murine macrophages. Eur. J. Biochem. 213, 833-839.
33. Nathan, C., and Xie, Q.-W. (1994) Nitric oxide syntheses: Roles, tolls, and controls. Cell 78, 915-918.
34. Giovanelli, J., Campos, K. L., and Kaufman, S. (1991) Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase does not function as a reactant in the oxygenation of arginine. Proc. Natl. Acad. Sci. USA 88, 7091-7095.
35. Marletta, M. A. (1993) Nitric oxide synthase: Structure and mechanism. J. Biol. Chem. 268, 12,231-12,234.
36. Schmidt, K., Werner, E. R., Mayer, B., Wachter, H., and Kukovets, W. R. (1992) Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem. J. 281, 297-300.
37. Baek, K. J., Thiel, B. A., Lacas, S., and Stuehr, D. J. (1993) Macrophage nitric oxide synthase subunits. Purification, characterization and role of prosthetic groups and substrate in regulating their association into a dimeric groups and substrate in regulating their association into a dimeric enzyme. J. Biol. Chem. 268, 21,120-21,129.
38. Werner-Felmayar, G., Werner, E. R., Fuchs, D., Hausen, A., Reibnegger, G., Schmidt, K., Weiss, G., and Wachter, H. (1993) Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J. Biol. Chem. 268, 1842-1846.
39. Sakai, N., Kaufman, S., and Milstien, S. (1995) Parallel induction of nitric oxide and tetrahydrobiopterin synthesis by cytokines in rat glial cells. J. Neurochem. 65, 895-902.
40. Ota, A., Yoshida, S., Nomura, T., Matsui, S., Hagino, Y., Umezawa, K., Katoh, S., and Nagatsu, T. (1996) Tetrahydrobiopterin biosynthesis enhanced by lipopolysaccharide stimulation in murine neuroblastoma cell line N1E-115. J. Neurochem. 67, 2540-2548.
41. Yoshida, S., Ota, A., Umezawa, K., and Nagatsu, T. (1996) Dissociated release of lipopolysaccharide from mouse neuroblastoma cells. Neurosci. Lett. 212, 135-138.
42. Pastor, C. M., Williams, D., Yoneyama, T., Hatakeyama, K., Singleton, S., Naylor, E., and Billiar, T. R. (1996) Competition for tetrahydrobiopterin between phenylalanine hydroxylase and nitric oxide synthase in rat liver. J. Biol. Chem. 271, 24,534-24,538.
43. Kinoshita, H., Tsutsui, M., Milstien, S., and Katusic, Z. (1997) Tetrahydrobiopterin, nitric oxide and regulation of cerebral arterial tone. Prog. Neurobiol. 52, 295-302.
44. Sabban, E. L. (1996) Synthesis of dopamine and its regulation, in CNS Neurotransmitters and Neuromodulators Dopamine (Stone, T. W., ed.), CRC, Boca Raton, Fl, pp. 1-20.
45. Waymire, J. C., Ayling, J. E., and Graviso, G. L. (1993) Nicotinic cholinergic regulation of tetrahydrobiopterin levels in bovine adrenal chromaffin cells. Adv. Exp. Med. Biol. 338, 235-238.
46. Nakanishi, N., Onozawa, S., Isono, A., Hara, M., Hasegawa, H., and Yamada, S. (1993) Long-term treatment of PC12 pheochromocytoma with dibutyryl cyclic AMP increases biopterin content in the cells but decreases in the medium. Adv. Exp. Biol. Med. 338, 231-234.
47. Abou-Doinia, M., Wilson, S. P., Zimmerman, T. P., Nichol, C. A., and Viveros, O. H. (1986) Regulation of guanosine triphosphate cyclohydrolase and tetrahydrobiopterin levels and the role of the cofactor in tyrosine hydroxylation in primary cultures of adrenomedullary chromaffin cells. J. Neurochem. 46, 1190-1199.
48. Zhu, M., Hirayama, K., and Kapatos, G. (1994) Regulation of tetrahydrobiopterin biosynthesis in cultured dopamine neurons by depolarization and cAMP. J. Biol. Chem. 269, 11,825-11,829.
49. Mori, A., Nakashima, A., Nagatsu, T., and Ota, A. (1997) Effect of lipopolysaccharide on the gene expression of the enzymes involved in tetrahydrobiopterin de novo synthesis in murine neuroblastoma cell line N1E-115. Neurosci. Lett. 237, 1-4.
50. Koshimura, K., Miwa, S., Lee, K., Fujiwara, M., and Watanabe, Y. (1990) Enhancement of dopamine release in vivo from the rat striatum by dialytic perfusion of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin. J. Neurochem. 54, 1391-1397.
51. Koshimura, K., Takagi, Y., Miwa, S., Kido, T., Watanabe, Y., Murakami, Y., Kato, Y., and Masaki, T. (1995) Characterization of a dopamine-releasing action of 6R-L-erythrotetrahydrobiopterin: Comparison with a 6S-form. J. Neurochem. 65, 827-830.
52. Imaizumi, K., Sasaki, T., Takahashi, K., and Takai, Y. (1994) Identification of a rabphilin-3A-interacting protein to GTP cyclohydrolase I in PC12 cells. Biochem. Biophys. Res. Commun. 205, 1409-1416.
53. Tanaka, K., Kaufman, S., and Milstein, S. (1989) Tetrahydrobiopterin, the cofactor for aromatic amino acid hydroxylases, is synthesized by and regulates proliferation of erythroid cells. Proc. Natl. Acad. Sci. USA 86, 5864-5867.
54. Laffranchi, R., Schoedon, G., Blau, N., and Spinas, G. A. (1997) Tetrahydrobiopterin synthesis precedes nitric oxide-dependent inhibition of insulin secretin in ISN-1 rat pancreatic β-cells. Biochem. Biophys. Res. Commun. 233, 66-70.
55. Segawa, M., Hosaka, A., Miyagawa, F., Nomura, Y., and Imai, H. (1976) Hereditary progressive dystonia with marked diurnal fluctuation. Adv. Neurol. 14, 215-233.
56. Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K., and Nagatsu, T. (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet. 8, 236-242.
57. Ichinose, H., Ohye, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K., and Nagatsu, T. (1995) GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation. Neurosci. Lett. 196, 5-8.
58. Hirano, M., Tamaru, Y., Nagai, Y., Ito, H., Imai, T., and Ueno, S. (1995) Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia/dopa responsive dystonia. Biochem. Biophys. Res. Commun. 213, 645-651.
59. Brandmann, O., Nygaard, T. G., Surtees, R., Marsden, C. D., Wood, N. W., and Harding, A. E. (1996) Dopa-responsive dystonia in British patients: New mutations of the GTP cyclohydrolase I gene and evidence for genetic heterogeneity. Hum. Mol. Genet. 5, 403-406.
60. Furukawa, Y., Shimadzu, M., Rajput, A. H., Shimizu, Y., Tagawa, T., Mori, H., Yokochi, M., Narabayashi, H., Hornykiewicz, O., Mizuno, Y., and Kish, S. J. (1996) GTP-cyclohydrolase I gene mutations in hereditary progressive and doparesponsive dystonia. Ann. Neurol. 39, 609-617.
61. Hirano, M., Tamaru, Y., Ito, H., Matsumoto, S., Imai, T., and Ueno, S. (1996) Mutant GTP cyclohydrolase I mRNA levels contribute to doparesponsive dystonia. Ann. Neurol. 40, 796-798.
62. Beyer, K., Ladoniga J.-V., Becino-Bilbao B., Cacabelos R., and Fuente-Fernández R. de la. (1997) A novel point mutation in the GTP cyclohydrolase I gene in a Spanish family with hereditary progressive and dopa responsive dystonia. Lancet 349, 420-421.
63. Hirano, M., Imaiso, Y., and Ueno, S. (1997) Differential splicing of the GTP cyclohydrolase I RNA in dopa-responsive dystonia. Biochem. Biophys. Res. Commun. 234, 316-319.
64. Hyland, K., Fryburg, J. S., Wilson, W. G., Bebin, E. M., Arnold, L. A., Guanasekara, R. S., Jacobson, R. D., Rost-Ruffner, E., and Trugman, J. M. (1997) Oral phenylalanine loading in doparesponsive dystonia: A possible diagnostic test. Neurology 48, 1290-1296.
65. Ozelius, L. J., and Breakfield, X. O. (1994) Co-factor insufficiency in dystonia-parkinsonian syndrome. Nature Genet. 8, 207-209.
66. Niederwieser, A., Blau, N., Wang, M., Joller, P., Atarés, M., and Cardia-Garcia, J. (1984) GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine and serotonin deficiencies and muscular hypotonia. Eur. J. Pediatr. 141, 208-214.
67. Blau, N., Ichinose, H., Nagatsu, T., Heizmann, C. W., Zacchello, F., and Burlina, A. B. (1995) A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program. J. Pediatr. 126, 401-405.
68. Ichinose, H., Ohye, T., Matsuda, Y., Hori, T., Balu, N., Burliner, A., Rouse, B., Matalon, R., Fujita, K., and Nagatsu, T. (1995) Characterization of mouse and human GTP cyclohydrolase I gene. Mutation in patients with GTP cyclohydrolase I deficiency. J. Biol. Chem. 270, 10,062-10,071.
69. Blau, N., Joller, P., Atarés, M., Cardesa-Garcia, J., and Niederwieser, A. (1985) Increase of GTP cyclohydrolase I activity in mononuclear blood cells by stimulation: Detection of heterozygotes of GTP cyclohydrolase I deficiency. Clin. Chim. Acta 148, 47-52.
70. Lüdecke, B., Dworniczak, B., and Bartholomé, K. (1995) A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum. Genet. 95, 123-125.
71. Knappskog, P. M., Flatmark, T., Mallet, J., Lüdecke, B., and Bartholomé, K. (1995) Recessively inherited L-dopa-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4, 1209-1212.
72. Lüdecke, B., Knappskog, P. M., Clayton, P. T., Surtees, S. J. R., Brand, M. P., Bartholomé, K., and Flatmark, T. (1996) Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 5, 1023-1028.
73. Flatmark, T., Knappskog, P. M., Bjøorgo, E., and Martinez, A. (1997) Molecular characterization of disease related mutant forms of human phenylalanine hydroxylase and tyrosine hydroxylase. Pteridines 8, 58.
74. Nagatsu, T., and Ichinose, H. (1991) Comparative studies on the structure of human tyrosine hydroxylase with those of the enzyme of various mammals. Comp. Biochem. Physiol. 98C, 203-210.
75. Zhou, Q.-Y., Quaife, C. J., and Palmiter, R. D. (1995) Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374, 640-643.
76. Kobayashi, K., Morita, S., Sawada, H., Mizuguchi, T., Yamada, K., Nagatsu, I., Hata, T., Watanabe, Y., Fujita, K., and Nagatsu, T. (1995) Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J. Biol. Chem. 270, 27,235-27,243.
77. Mogi, M., Harada, M., Kiuchi, K., Kondo, T., Narabayashi, H., Rausch, D., Riederer, P., Jellinger, K., and Nagatsu, T. (1988) Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in Parkinsonian brain. J. Neural Transm. 72, 77-81.
78. Grima, B., Lamouroux, A., Boni, C., Julien, J.-F., Jovoy-Agid, F., and Mallet, J. (1997) A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 326, 707-711.
79. Kaneda, N., Kobayashi, K., Ichinose, H., Kishi, F., Nakazawa, A., Kurosawa, Y., Fujita, K., and Nagatsu, T. (1987) Isolation of a novel cDNA clone for human tyrosine hydroxylase: Alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem. Biophys. Res. Commun. 146, 971-975.
80. Ichinose, H., Ohye, T., Fujita, K., Pantucek, F., Lange, K., Riederer, P., and Nagatsu, T. (1994) Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia. J. Neural Transm. 8, 149-158.
81. Nagatsu, I., Ichinose, H., Sakai, M., Titani, K., Suzuki, M., and Nagatsu, T. (1995) Immunocytochemical localization of GTP cyclohydrolase I in the brain, adrenal gland, and liver of mice. J. Neural. Transm. 102, 175-188.
82. Lentz, S. I., and Kapatos, G. (1996) Tetrahydrobiopterin biosynthesis in the rat brain: Heterogeneity of GTP cyclohydrolase I mRNA expression in monoamine containing neurons. Neurochem. Int. 28, 569-582.
83. Hirayama, K., and Kapatos, G. (1998) Nigrostriatal dopamine neurons express low levels of GTP cyclohydrolase I protein. J. Neurochem. 70, 164-170.
84. Blau, N., Barnes, I., and Dhondt, J. L. (1996) International detabase of tetrahydrobiopterin deficiencies. J. Inher. Metab. Dis. 19, 8-14.
85. Kaufman, S., Kapatos, G., Rizzo, W., Schulman, J. D., Tamarkin, L., and Van Loon, G. L. (1983) Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin. Ann. Neurol. 14, 308-315.
86. Thöny, B., and Blau, N. (1997) Mutations in the GTP cyclohydrolase I and 6-pyruvayl-tetrahydropterin synthase genes. Hum. Mutat. 10, 11-20.
87. Oppliger, T., Thöny, B., Nar, H., Bürgisser, D., Huber, R., Heizmann, C. W., and Blau, N. (1995) Structural and functional consequences of mutations in 6-pyruvoyltetrahydropterin synthase causing hyperphenylalaninemia in humans. Phosphorylation is a requirement for in vivo activity. J. Biol. Chem. 270, 29,498-29,506.
88. Hanihara, T., Inoue, K., Kawanishi, C., Sugiyama, N., Miyakawa, T., Onishi, H., Yamada, Y., Osaka, H., Kosaka, K., Iwabuchi, K., and Owada, M. (1997) 6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: A clinical and molecular study. Movement Disord. 12, 408-411.